VPS53 Suppresses Malignant Properties in Colorectal Cancer by Inducing the Autophagy Signaling Pathway
Related Experiment Video
Updated: Dec 3, 2025

In vitro Organoid Culture of Primary Mouse Colon Tumors
Published on: May 17, 2013
Hong Peng1, Jie Zheng2, Qiang Su3
1Department of Anorectal Surgery, Nanchong Central Hospital, The Second Clinical Medical College, North Sichuan Medical College, Nanchong, Sichuan, 637000, People's Republic of China.
Background:
Many studies found that VPS53, one of the subunits of the golgi-associated retrograde protein (GARP) complexes, was aberrantly expressed in human diseases.
Aim:
This study investigated the functions and molecular mechanisms of VPS53 in colorectal cancer (CRC).
Methods:
Expression and correlation of Beclin 1 and VPS53 were analyzed by RT-qPCR and Pearson's correlation in CRC tissues, and VPS53 expression was also determined in CRC cells. The changes of proliferation, migration, invasion, apoptosis, and autophagy of CRC cells were examined by a succession of functional experiments including CCK-8, flow cytometry, transwell assay, and electron microscopy. The levels of autophagy related proteins were evaluated by Western blotting analysis.
Results:
RT-qPCR results found that VPS53 was downregulated in CRC tissues and cells, and Beclin 1 expression was also decreased in CRC tissues. There was a positive correlation between VPS53 and Beclin 1. Functional results showed that overexpression of VPS53 could suppress proliferation, migration, and invasion, and accelerate apoptosis and autophagy of CRC cells. Also, VPS53 could upregulate Beclin 1 and LC3BII, suggesting the inductive effect of VPS53 on CRC cell autophagy. Furthermore, it was found that the autophagy inhibitor (Inhb) could attenuate the inhibition of VPS53 on CRC progression.
Conclusion:
VPS53 repressed CRC progression by regulating the autophagy signaling pathway, suggesting that VPS53 might be a promising therapeutic target for CRC.
Insights
VPS53, a Golgi-associated retrograde protein complex subunit, is downregulated in colorectal cancer (CRC). Its restoration suppresses CRC progression by enhancing autophagy, suggesting VPS53 as a potential therapeutic target.
Area of Science:
- Oncology
- Molecular Biology
- Cell Biology
Background:
- VPS53, a subunit of the Golgi-associated retrograde protein (GARP) complex, exhibits aberrant expression in various human diseases.
- Understanding the role of VPS53 in colorectal cancer (CRC) is crucial for developing new therapeutic strategies.
Purpose of the Study:
- To investigate the functional roles and underlying molecular mechanisms of VPS53 in colorectal cancer (CRC).
- To explore the relationship between VPS53 and Beclin 1 in CRC progression.
Main Methods:
- Quantitative real-time PCR (RT-qPCR) and Pearson's correlation analysis were used to assess VPS53 and Beclin 1 expression and their correlation in CRC tissues and cells.
- Functional assays including CCK-8, flow cytometry, Transwell assays, and electron microscopy were employed to evaluate the impact of VPS53 on CRC cell proliferation, migration, invasion, apoptosis, and autophagy.
- Western blotting was utilized to analyze the levels of autophagy-related proteins.
Main Results:
- VPS53 and Beclin 1 were found to be downregulated in CRC tissues and cells, with a positive correlation between their expression.
- Overexpression of VPS53 suppressed CRC cell proliferation, migration, and invasion while promoting apoptosis and autophagy.
- VPS53 upregulated Beclin 1 and LC3BII, indicating its role in inducing autophagy, and an autophagy inhibitor attenuated VPS53's inhibitory effects on CRC progression.
Conclusions:
- VPS53 plays a suppressive role in colorectal cancer progression by modulating the autophagy signaling pathway.
- VPS53 represents a potential therapeutic target for colorectal cancer treatment.
More Related Videos
06:24Author Spotlight: Liujunzi Decoction as a Traditional Chinese Treatment for Coloproctitis Cancer
Published on: October 13, 2023
09:29Development and Maintenance of a Preclinical Patient Derived Tumor Xenograft Model for the Investigation of Novel Anti-Cancer Therapies
Published on: September 30, 2016
Related Concept Videos
Abnormal Proliferation
PI3K/mTOR/AKT Signaling Pathway
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
Cancer-Critical Genes II: Tumor Suppressor Genes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Autophagic Cell Death
Autophagy and Apoptosis
Autophagy can activate apoptosis. In normal conditions, the autophagy activating protein Beclin-1 and...
Loss of Tumor Suppressor Gene Functions
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...